Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study
ESC Heart Failure · 04.07.2026 · 13 (4)
DOI: 10.1093/eschf/xvag170 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ESC Heart Failure, online erschienen am 03.07.2026. Verfasst von Damiano Magrì und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, 'Sapienza' University of Rome, Via Giorgio Nicola Papanicolau, 00189 Rome, Italy. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Cardiomyopathies, Heart Rate, Exercise Tolerance. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: DigiCardiopaTh PhD program, Sapienza University of Rome, Pfizer.
Abstract (Originalsprache)
Introduction
Chronotropic incompetence (CI) is a frequent but underappreciated feature of cardiac amyloidosis and may contribute to exercise intolerance. However, its prognostic significance remains incompletely defined. We investigated the prevalence, functional correlates, and prognostic value of chronotropic incompetence in patients with transthyretin amyloid cardiomyopathy.
Methods
In this multicentre retrospective study, 212 stable outpatients with transthyretin amyloid cardiomyopathy, in sinus rhythm and naïve to disease-specific therapy, underwent maximal cardiopulmonary exercise testing. Chronotropic response was assessed as peak heart rate expressed as a percentage of the age-predicted value (pHR%). Chronotropic incompetence prevalence was evaluated using clinically relevant thresholds. Prognostic performance for 1-year cardiovascular mortality was assessed using Cox regression, receiver operating characteristic analysis, and Kaplan–Meier estimates.
Results
Chronotropic incompetence defined by a pHR% ≤75% was present in 35% of patients and was associated with markedly impaired functional capacity, including lower peak oxygen uptake and reduced ventilatory efficiency. During 1-year follow-up, 10 cardiovascular deaths occurred. Among exercise-derived variables, pHR% demonstrated strong prognostic value, with each 1% increase associated with a 5.5% relative reduction in cardiovascular mortality risk (hazard ratio 0.945; P = .011). A pHR% threshold of 75% provided optimal discrimination (area under the curve 0.71) and identified a subgroup with significantly lower survival (log-rank P < .05).
Conclusion
A blunted chronotropic response is common in transthyretin amyloid cardiomyopathy and conveys adverse short-term prognosis. A pHR% ≤75% represents a clinically meaningful and easily obtainable threshold for functional and prognostic stratification, offering a pragmatic alternative when comprehensive cardiopulmonary exercise testing assessment is not available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, 'Sapienza' University of Rome, Via Giorgio Nicola Papanicolau, 00189 Rome, Italy.
- Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
- Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.
- Division of Cardiology, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
- Department of Public Health and Epidemiology, Khalifa University, Abu Dhabi, United Arab Emirates.
- Department of Economia, Statistica e Finanza 'Giovanni Anania'-University of Calabria, Cosenza, Italy.
ORCID-Profile: Damiano Magrì, Antonello Maruotti, Sara Corradetti, Christina Kronberger, Giuseppe Vergaro, Irene Mattavelli, Emanuele Barbato, Piergiuseppe Agostoni, Emiliano Fiori
Förderung
- DigiCardiopaTh PhD program
- Sapienza University of Rome
- Pfizer
Zitieren
APA
Magrì, D., Ermolaev, N., Castiglione, V., Willixhofer, R., Maruotti, A., Corradetti, S., Russo, A., Chen, Y. F. F., Capelle, C. D. J., Kronberger, C., Vergaro, G., Passino, C., Salvioni, E., Mattavelli, I., Piotti, A., Emdin, M., Barbato, E., Agostoni, P., Fiori, E., & Eslam, R. B. (2026). Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study. ESC Heart Failure, 13(4). https://doi.org/10.1093/eschf/xvag170
Vancouver
Magrì D, Ermolaev N, Castiglione V, Willixhofer R, Maruotti A, Corradetti S, et al. Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study. ESC Heart Failure. 2026;13(4). doi:10.1093/eschf/xvag170
BibTeX
@article{Magr2026,
author = {Magrì, Damiano and Ermolaev, Nikita and Castiglione, Vincenzo and Willixhofer, Robin and Maruotti, Antonello and Corradetti, Sara and Russo, Alfonso and Chen, Yu Fu Ferrari and Capelle, Christophe D J and Kronberger, Christina and Vergaro, Giuseppe and Passino, Claudio and Salvioni, Elisabetta and Mattavelli, Irene and Piotti, Arianna and Emdin, Michele and Barbato, Emanuele and Agostoni, Piergiuseppe and Fiori, Emiliano and Eslam, Roza Badr},
title = {Prognostic impact of chronotropic incompetence in transthyretin cardiac amyloidosis: a multicentre study},
journal = {ESC Heart Failure},
year = {2026},
volume = {13},
number = {4},
doi = {10.1093/eschf/xvag170}
}
EUVIMED